Inovalon Holdings Inc

Inovalon — Q4 and FY2015 Earnings Presentation

27 slides from Inovalon's earnings presentation, Feb 25, 2016

  1. Slide 1: Note Regarding Forward-Looking Statements

    Slide 1: Note Regarding Forward-Looking Statements

    Note Regarding Forward-Looking Statements This presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, including, but not limited to, statements regarding future results of the operations and financial position of Ino

  2. Slide 2: Our Balance: Innovation, Growth, Profitability

    Slide 2: Our Balance: Innovation, Growth, Profitability

    Our Balance Innovation Growth Profitability 3 INOV Q4 & FY 2015 Supplement (2.25.16) v1.0.0 © 2016 by Inovalon. All rights reserved.

  3. Slide 3: Our 5-Year View

    Slide 3: Our 5-Year View

    Our 5-Year View •1 Growth at a rate of more than 2x that of our market, achieving revenue of more than $1 billion by 2020 •2 Margin expansion at a rate of more than 100 bp per year, achieving EBITDA margins of more than 40% by 2020 •3 Diversifying client base achieving customer de-concentration by 2

  4. Slide 4: Expanding Proprietary Datasets

    Slide 4: Expanding Proprietary Datasets

    Expanding Proprietary Datasets Inovalon’s proprietary datasets contain data pertaining to more than: • • 784,000 physicians 269,000 clinical facilities • • 130 million unique patients 11.0 billion medical events MORE2 Registry® Growth: Bar chart reflects annual data as of December 31st of each year.

  5. Slide 5: Revenue Growth

    Slide 5: Revenue Growth

    Revenue Growth $510 - $520 20% 2010 – 2016G CAGR $437 $362 $300 $296 $240 2011 2012 2013 2014 2015 2016 Guidance All dollars shown in millions. 2016 Guidance is per the Company’s Q4 2015 earnings release and conference call held on February 25, 2016. CAGR calculations undertaken to the mid-point of

  6. Slide 6: Adjusted EBITDA Growth

    Slide 6: Adjusted EBITDA Growth

    Adjusted EBITDA Growth 28% 2010 – 2016G CAGR $182 - $188 $152 $134 $108 $72 $58 37% 36% 36% 35% 24% 24% 2011 2012 2013 2014 2015 2016 Guidance % of Revenue All dollars shown in millions. 2016 Guidance is per the Company’s Q4 2015 earnings release and conference call held on February 25, 2016. CAGR c

  7. Slide 7: Non-GAAP Net Income Growth

    Slide 7: Non-GAAP Net Income Growth

    Non-GAAP Net Income Growth 29% 2010 – 2016G CAGR $88 - $92 $75 $70 $59 $37 $30 20% 19% 17% 17% 13% 13% 2011 2012 2013 2014 2015 2016 Guidance % of Revenue All dollars shown in millions. 2016 Guidance is per the Company’s Q4 2015 earnings release and conference call held on February 25, 2016. CAGR ca

  8. Slide 8: Cash Flow From Operations

    Slide 8: Cash Flow From Operations

    Cash Flow From Operations $130 - $140 43% 2010 – 2016E CAGR $86 $68 $66 $54 $46 26% 24% 22% 19% 18% 15% 2015(1) 20162E0s1t6imate Estimate(2) 2011 2012 2013 2014 % of Revenue (1) 2015 cash flow from operations was effected by revenue seasonality pushing cash collections to early 2016, and an increase

  9. Slide 9: Investment in Innovation

    Slide 9: Investment in Innovation

    Investment in Innovation 22% 2010 – 2016E CAGR $54 - $58 $48 $45 $35 $27 $21 12% 12% 11% 11% 9% 9% 2011 2012 2013 2014 % of Revenue 2015 2016 Estimate All dollars shown in millions. Investment in Innovation includes research and development expense, capitalized software development costs and researc

  10. Slide 10: Seasonality

    Slide 10: Seasonality

    Seasonality The nature of Inovalon’s customers’ end-market results in seasonality reflected in both revenue and margin differences during the year. 1 Regulatory impact of data submission deadlines in March, June, September, and January drive predictable timing of analytics and data processing activi

  11. Slide 11: Seasonality Trends – Revenue

    Slide 11: Seasonality Trends – Revenue

    Seasonality Trends – Revenue Seasonality of Inovalon revenue has been evolving over recent years. 29.6% 27.6% 27.9% 26.9% 24.8% 27.5% 26.6% 25.4% 23.4% 21.4% 19.0% 25.3% 23.8% 24.9% 21.8% 24.1% Percentages represent the portions of actual or projected revenue in each quarter. All figures are shown i

  12. Slide 12: Revenue Components

    Slide 12: Revenue Components

    Revenue Components Inovalon’s business model is a value-based model with a strong linkage between analytical solutions and client value creation. In this paradigm, the Company’s revenue is materially composed of two components: 1) Data Analytics Subscription Fees, and 2) Data-Driven Intervention Pla

  13. Slide 13: Financial Modeling

    Slide 13: Financial Modeling

    Financial Modeling For each revenue component described previously, Inovalon is providing the following metrics which convey a high-level description of how total revenue has built in 2015. 1 Client SOW Count: Each client enters into unique statements of work (SOWs) for each services that Inovalon p

  14. Slide 14: Fixed Subscription Fees

    Slide 14: Fixed Subscription Fees

    Fixed Subscription Fees Avg. Fixed Subscription Fee per Client SOW $151,151 As updated from December 7, 2015 Investor Day for actual full year 2015 results. 152 SOWs 72 SOWs 5 SOWs 5 SOWs 5 SOWs $841 $17,655 $151,151 $692,257 $1,650,738 Average Annual Fixed Subscription Fee Graph reflects a skewed b

  15. Slide 15: Monthly Analytics Fees

    Slide 15: Monthly Analytics Fees

    Monthly Analytics Fees Avg. Monthly Analytics Fee per Client SOW $719,397 As updated from December 7, 2015 Investor Day for actual full year 2015 results. 86 SOWs 59 SOWs 4 SOWs 4 SOWs 4 SOWs $2,063 $38,781 $719,397 $3,869,135 $8,238,738 Average Annual Total of Monthly Analytics Fee Graph reflects a

  16. Slide 16: Identified Gap Analytics Fee

    Slide 16: Identified Gap Analytics Fee

    Identified Gap Analytics Fee Avg. Identified Gap Analytics Fee per Client SOW $2,192,092 As updated from December 7, 2015 Investor Day for actual full year 2015 results. 17 SOWs 14 SOWs 2 SOW 1 SOW 1 SOW $17,401 $130,699 $2,192,092 $12,192,380 $13,375,526 Average Annual Identified Gap Analytics Fee

  17. Slide 17: Data-Driven Intervention Platform Fees

    Slide 17: Data-Driven Intervention Platform Fees

    Data-Driven Intervention Platform Fees Avg. Data-Driven Intervention Platform Fee per Client SOW $2,326,922 As updated from December 7, 2015 Investor Day for actual full year 2015 results. 47 SOWs 28 SOWs 3 SOWs 2 SOWs 2 SOWs $16,168 $90,775 $2,326,922 $14,680,361 $17,550,785 Average Annual Data-Dri

  18. Slide 18: Summary Revenue Model

    Slide 18: Summary Revenue Model

    Summary Revenue Model P Revenue Per SOW x Q Client SOW Count = R Revenue 19 INOV Q4 & FY 2015 Supplement (2.25.16) v1.0.0 © 2016 by Inovalon. All rights reserved. Fixed Subscription Fees$151,151239$36.1 Monthly Analytics Fees$719,397157$ 112.9 Gap Analytics Fees$2,192,09235$76.7 Intervention Platfor

  19. Slide 19: Balance Sheet Strength

    Slide 19: Balance Sheet Strength

    Balance Sheet Strength The strong balance sheet position positions Inovalon well for strategic expansion. All dollars shown in millions. 20 INOV Q4 & FY 2015 Supplement (2.25.16) v1.0.0 © 2016 by Inovalon. All rights reserved. December 31, 2015 Cash, Cash Equivalents and Short-Term Investments$728.2

  20. Slide 20: Acquisition Focus

    Slide 20: Acquisition Focus

    Acquisition Focus The following presents Inovalon’s view towards acquisition prioritization: Priority Description Impact Strategic strong client base, into which Inovalon’s data 1 Strategic strong technologies, which can be rapidly 2 Inovalon’s expansion in similar or adjacent 3 Revenue seeding for

  21. Slide 21: Summary Highlights

    Slide 21: Summary Highlights

    Summary Highlights 1 Highly differentiated technology leader serving large and growing end-market in a transformative period 2 Long track record of strong growth and material profitability at scale Multiple business tailwinds with significant runways for continued growth and margin expansion 3 22 IN

  22. Slide 22: Our 5-Year View

    Slide 22: Our 5-Year View

    Our 5-Year View •1 Growth at a rate of more than 2x that of our market, achieving revenue of more than $1 billion by 2020 •2 Margin expansion at a rate of more than 100 bp per year, achieving EBITDA margins of more than 40% by 2020 •3 Diversifying client base achieving customer de-concentration by 2

  23. Slide 23: Our 5-Year View

    Slide 23: Our 5-Year View

    . ae Our 5-Year View inovalon C1) Growth at a rate of more than 2x that of our market, achieving revenue of more than $1 billion by 2020 e Margin expansion at a rate of more than 100 bp per year, achieving EBITDA margins of more than 40% by 2020 © Diversifying client base achieving customer de-conce

  24. Slide 24: Reconciliation of Net Income to Adjusted EBITDA

    Slide 24: Reconciliation of Net Income to Adjusted EBITDA

    Reconciliation of Net Income to Adjusted EBITDA Year Ended December 31, 2015 2014 2013 2012 2011 (in thousands) Reconciliation of Net Income to Adjusted EBITDA: Net income ........................................................................................... Depreciation and amortization.......

  25. Slide 25: Reconciliation of Net Income to Non-GAAP net income

    Slide 25: Reconciliation of Net Income to Non-GAAP net income

    Reconciliation of Net Income to Non-GAAP net income Year Ended December 31, 2015 2014 2013 2012 2011 (in thousands) Reconciliation of Net Income to Non-GAAP net income: Net income ............................................................................................... Stock-based compensation

  26. Slide 26: healthcare empowered

    Slide 26: healthcare empowered

    healthcare empowered INOV Q4 & FY 2015 Supplement (2.25.16) vl.O.O

  27. Slide 27: Inovalon – healthcare empowered

    Slide 27: Inovalon – healthcare empowered

    hy, = Gi \\ ‘a wig inovalon healthcare empowered

Source: SEC EDGAR · 8-K filed Feb 25, 2016

More decks from Inovalon Holdings Inc